KPP Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.44M Sell
2,871
-460
-14% -$470K 0.44% 58
2026
Q1
$3.06M Sell
3,331
-141
-4% -$143K 0.44% 55
2025
Q4
$3.73M Sell
3,472
-412
-11% -$394K 0.54% 45
2025
Q3
$2.96M Buy
3,884
+349
+10% +$260K 0.44% 56
2025
Q2
$2.76M Buy
3,535
+368
+12% +$286K 0.45% 54
2025
Q1
$2.62M Buy
3,167
+35
+1% +$29.1K 0.5% 51
2024
Q4
$2.42M Buy
3,132
+101
+3% +$83.6K 0.57% 47
2024
Q3
$2.69M Buy
3,031
+169
+6% +$152K 0.64% 42
2024
Q2
$2.59M Sell
2,862
-157
-5% -$126K 0.69% 41
2024
Q1
$2.35M Sell
3,019
-29
-1% -$20.6K 0.64% 41
2023
Q4
$1.78M Sell
3,048
-310
-9% -$181K 1.56% 11
2023
Q3
$1.8M Buy
+3,358
New +$1.73M 0.6% 41

Other funds holding LLY

KPP Advisory Services's LLY Position: Q2 2026 in Review

KPP Advisory Services reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $470K and leaving 2,871 shares worth $3.44M. The position accounts for 0.44% of the portfolio, ranked #58.

KPP Advisory Services first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.73M in Q4 2025. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • KPP Advisory Services held 2,871 shares of Eli Lilly worth $3.44M as of Q2 2026.
  • KPP Advisory Services sold 460 Eli Lilly shares in Q2 2026, an estimated $470K.
  • Eli Lilly made up 0.44% of KPP Advisory Services's portfolio in Q2 2026, its #58 holding.
  • KPP Advisory Services first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • KPP Advisory Services's Eli Lilly position peaked at $3.73M in Q4 2025.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.